Evidence map›Paper›PMID 32482872›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4

Nadezhda N Logunova, Valeriia V Kriukova, Pavel V Shelyakin, Evgeny S Egorov, Alina Pereverzeva, Nina G Bozhanova, Mikhail Shugay, Dmitrii S Shcherbinin, Mikhail V Pogorelyy, Ekaterina M Merzlyak and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. T Cell Thoughts.Immunological reviews · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Nadezhda N LogunovaLaboratory for Immunogenetics, Central Institute for Tuberculosis, Moscow, 107564, Russia.ORCID 0000-0001-7086-6158
Valeriia V KriukovaDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Pavel V ShelyakinDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Evgeny S EgorovDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.ORCID 0000-0002-6495-7173
Alina PereverzevaDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Nina G BozhanovaCenter for Structural Biology, Vanderbilt University, Nashville, TN 37235.ORCID 0000-0002-2164-5698
Mikhail ShugayDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.ORCID 0000-0001-7826-7942
Dmitrii S ShcherbininInstitute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, 117997, Russia.
Mikhail V PogorelyyDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Ekaterina M MerzlyakDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Vasiliy N ZubovDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.
Jens MeilerCenter for Structural Biology, Vanderbilt University, Nashville, TN 37235.
Dmitriy M ChudakovDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia.ORCID 0000-0003-0430-790X
Alexander S AptLaboratory for Immunogenetics, Central Institute for Tuberculosis, Moscow, 107564, Russia; alexapt0151@gmail.com olbritan@gmail.com.ORCID 0000-0002-3683-3085
Olga V BritanovaDepartment of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997, Russia; alexapt0151@gmail.com olbritan@gmail.com.
Institute of Bioorganic Chemistry · RUPirogov Russian National Research Medical University · RUSkolkovo Institute of Science and Technology · RUCentral Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RUVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety of antigenic peptides displayed in a given major histocompatibility complex (MHC) context. Complementarity-determining region 3 (CDR3) is the most variable part of the TCRα and -β chains, which govern interactions with peptide-MHC complexes. However, it remains unclear how the CDR3 landscape is shaped by individual MHC context during thymic selection of naïve T cells. We established two mouse strains carrying distinct allelic variants of

Indexed as

AllelesAnimalsCD4-Positive T-LymphocytesComplementarity Determining RegionsHistocompatibility Antigens Class IIHumansMiceMice, Inbred C57BLReceptors, Antigen, T-CellSpleenT-Lymphocytes, RegulatoryTuberculosisComplementarity Determining RegionsHistocompatibility Antigens Class IIReceptors, Antigen, T-CellMHC-IInaïve CD4+ T cellsregulatory T cellsTCR repertoire landscape

Identifiers

PMID32482872
PMCPMC7306996
OpenAlexW3032559793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.